THE EFFECT OF TIME TO CASTRATION RESISTANCE ON SURVIVAL IN PATIENTS WITH METASTATIC HORMONE-NAIVE PROSTATE CANCER: A MULTICENTER RETROSPECTIVE STUDY

被引：0
|
作者：
Tokui, Noriko
Hatakeyama, Shingo
Narita, Satoshi
Yoneyama, Takahiro
Hashimoto, Yasuhiro
Ohyama, Chikara
机构：
来源：
JOURNAL OF UROLOGY | 2020年 / 203卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP37-12
引用
收藏
页码：E564 / E565
页数：2
相关论文
共 50 条
  • [21] Editorial Comment to Effect of upfront combination therapy on the overall survival of patients with metastatic castration-sensitive prostate cancer: A multicenter retrospective study
    Shiota, Masaki
    INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 (05) : 478 - 479
  • [22] The optimal treatment of metastatic hormone-naive prostate cancer: abiraterone acetate or docetaxel?
    Aoun, Fouad
    El Rassy, Elie
    Sleilaty, Ghassan
    Assi, Tarek
    Bakouny, Ziad
    Kattan, Joseph
    FUTURE ONCOLOGY, 2017, 13 (30) : 2785 - 2790
  • [23] Zoledronic acid combined with androgen-deprivation therapy may prolong time to castration-resistant prostate cancer in hormone-naive metastatic prostate cancer patients - A propensity scoring approach
    Nagao, Kazuhiro
    Matsuyama, Hideyasu
    Nozawa, Masahiro
    Hara, Isao
    Nishioka, Tsukasa
    Komura, Takahiro
    Esa, Atsunobu
    Uejima, Shigeya
    Imanishi, Masaaki
    Uekado, Yasunari
    Ogawa, Takatoshi
    Kajikawa, Hiroshi
    Uemura, Hirotsugu
    ASIAN JOURNAL OF UROLOGY, 2016, 3 (01) : 33 - 38
  • [24] Prediction of Time to Castration-Resistant Prostate Cancer Using Low-Molecular-Weight Protein Tyrosine Phosphatase Expression for Men with Metastatic Hormone-Naive Prostate Cancer
    Miyoshi, Yasuhide
    Ohtaka, Mari
    Kawahara, Takashi
    Ohtake, Shinji
    Yasui, Masato
    Uemura, Koichi
    Yoneyama, Shuko
    Yokomizo, Yumiko
    Uemura, Hiroji
    Miyamoto, Hiroshi
    Yao, Masahiro
    UROLOGIA INTERNATIONALIS, 2019, 102 (01) : 37 - 42
  • [25] Enzalutamide monotherapy: Phase II study results in patients with hormone-naive prostate cancer
    Tombal, Bertrand
    Borre, Michael
    Rathenborg, Per
    Werbrouck, Patrick
    Heidenreich, Axel
    Iversen, Peter
    Baskin-Bey, Edwina S.
    Perabo, Frank
    Phung, De
    Smith, Matthew Raymond
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [26] ASSOCIATION OF TUMOR BURDEN WITH THE ELIGIBILITY OF UPFRONT THERAPY IN PATIENTS WITH CASTRATION NAIVE PROSTATE CANCER: A MULTICENTER RETROSPECTIVE STUDY
    Tanaka, Toshikazu
    Iwamura, Hiromichi
    Hatakeyama, Shingo
    Narita, Shintaro
    Takahashi, Masahiro
    Toshihiko, Sakurai
    Kawamura, Sadafumi
    Hoshi, Senji
    Ishida, Masanori
    Kawaguchi, Toshiaki
    Ishidoya, Shigeto
    Shimoda, Jiro
    Sato, Hiromi
    Hamano, Itsuto
    Okamoto, Teppei
    Mitsuzuka, Koji
    Ito, Akihiro
    Tsuchiya, Norihiko
    Arai, Yoichi
    Habuchi, Tomonori
    Ohyama, Chikara
    JOURNAL OF UROLOGY, 2020, 203 : E563 - E564
  • [27] Time to Castration Resistance is Associated With Overall Survival Even After the Achievement of Castration Resistance in Metastatic Prostate Cancer
    Kato, Hiroto
    Goto, Yusuke
    Kojima, Satoko
    Onoda, Yusuke
    Wakai, Ken
    Hou, Kyokushin
    Araki, Kazuhiro
    Sakamoto, Shinichi
    Ichikawa, Tomohiko
    Naya, Yukio
    PROSTATE, 2025, 85 (05): : 471 - 481
  • [28] Pretreatment Lymphocyte to C-Reactive Protein Ratio: An Independent Predictor of Overall Survival in Metastatic Hormone-Naive Prostate Cancer Patients
    Sasaki, Takeshi
    Takahashi, Toshifumi
    Sekito, Sho
    Kanda, Hideki
    Higashi, Shinichiro
    Masui, Satoru
    Kojima, Takahiro
    Matsuura, Hiroshi
    Nishikawa, Kouhei
    Akamatsu, Shusuke
    Okugawa, Yoshinaga
    Kobayashi, Takashi
    Inoue, Takahiro
    CLINICAL GENITOURINARY CANCER, 2023, 21 (06) : E474 - E484
  • [29] Retrospective validation of bone risk stratification criteria for men with de novo metastatic hormone-naive prostate cancer in China
    Zhang, Yang
    Ding, Li
    Zheng, Yuxin
    Wang, Kun
    Xia, Wentao
    Wang, Junqi
    Ge, Peng
    PEERJ, 2023, 11
  • [30] Impact of germline DNA-repair gene BRCA2 and CHEK2 mutations on time to castration resistance in patients with metastatic hormone-naive prostate cancer: A single center analysis.
    Matveev, Vsevolod Borisovich
    Lyubchenko, Liudmila
    Kirichek, Andrey
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345